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ABSTRACT
Cordycepin is an analogue of adenosine lacking the 3'-OH. When incorporated into a
growing RNA molecule, cordycepin prevents further elongation, thus producing a pre-
maturely terminated RNA molecule. When HeLa cells are exposed to low concentrations
of cordycepin, DNA and protein synthesis are unaffected during short exposure periods .
The synthesis of completed ribosomal and ribosomal-precursor (45S) RNA is significantly
depressed. Partially completed 45S ribosomal precursor molecules accumulate in the
nucleolus. 18S ribosomal RNA can be cleaved from these incomplete precursors, while
32S ribosomal precursor cannot be produced from partially snythesized 45S molecules .
The synthesis of transfer RNA is also reduced in the presence of cordycepin. The synthesis
of the nuclear heterogeneous RNA species is unaffected by the drug while the cytoplasmic
heterogeneous RNA is slightly reduced.
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INTRODUCTION
The nucleolus is a specialized and highly organized
structure in the cell, whose principal and perhaps
only function is the production of ribosomes (1-3).
Nucleolar function can be easily disrupted by
agents which interfere with nucleic acid or protein
synthesis. Nucleolar synthesis is inhibited more
rapidly and at lower doses of these various agents
than the synthesis of other species of RNA (1, 4, 5) .
Thus, levels of actinomycin which have little effect
on most cellular RNA metabolism can completely
inhibit nucleolar synthesis. Mitomycin C, which
inhibits RNA synthesis by a very different mecha-
nism than actinomycin, also causes selective nucle-
olar inhibition (R . Laing and S. Penman. Unpub-
lished observation).
Another class of agents is incorporated into
nucleolar RNA and interferes with normal process-
ing. Examples are : toyocamycin, tubercidin, and
azaguanine (6, 7) .
Cordycepin (3' deoxyadenosine) is a unique
agent which can interfere with the synthesis of
complete molecules (8) . Cordycepin triphosphate
has been shown to cause premature termination of
RNA synthesized in vitro by DNA-dependent
RNA polymerase (9, 18).
The effects of cordycepin on HeLa cell RNA
metabolism are described in this report. This drug
is selective and principally affects nucleolar syn-
thesis. Ribosomal precursor molecules are pre-
maturely terminated . Apparently only 18S ribo-
somal RNA can be produced from these shortened
molecules.
The principal heterogeneous high molecular
weight species of RNA are relatively unaffected by
the drug. However, tRNA' synthesis is also af-
fected.
'The following abbreviations are used : TCA,
trichloroacetic acid . SDS, sodium dodecyl sulfate.MATERIALS AND METHODS
HeLa cells were grown in suspension culture as pre-
viously described (10).
Labeling and fractionation of cells were carried out
as previously described (11). The subfractionation of
the nuclei was carried out by the method described
by Penman, Smith, and Holtzman (3). Zonal cen-
trifugation for isolating nucleoli as described by
Willems, Wagner, Laing, and Penman was used (12).
RNA extraction was performed with the hot phenol-
SDS method described by Scherrer and Darnell (13)
which was modified by additional hot chloroform
extraction (3).
The analysis of RNA was performed with SDS-
sucrose as previously described (14) or by acrylamide
gel electrophoresis first described by Loening (15)
which was subsequently modified to include glyc-
erol in the gels (16).
3'-dA, cordycepin. nRNA, nuclear heterodisperse
RNA. tRNA, transfer RNA. rRNA, ribosomal RNA.
PRPP, phosphoribosyl pyrophosphate . ATP, adeno-
sine triphosphate. AMP, adenosine monophosphate.
3'-dATP, 3'-deoxyadenosine triphosphate . cRNA,
cytoplasmic heterodisperse RNA .
FIGURE 1 The effect of cordycepin on macromolecular synthesis. HeLa cells were concentrated to 2 X 106/
ml and preincubated with cordycepin for 10 min . The labeled precursors were then added. At the indi-
cated times, 0.2 ml samples were pipetted into 5 ml of cold Earle's saline and centrifuged. The cell pellet
was resuspended in 0.2 ml of distilled water, precipitated with 2 ml of cold 107 TCA, collected on Milli-
pore filters, and washed with 5% TCA. For the amino acid incorporation, this procedure was modified by
the addition of 0.5 ml of 1 x KOH to the resuspended cell pellet . 15 min later, 1 ml of 20% TCA was
added, and the samples were filtered and washed as before. Labeled isotopes were added as follows : uri-
dine-14C, 0.1 µc/ml; thymidine 14C, 0.1 µc/ml ; reconstituted protein hydrolysate-14C, 0.5 tc/ml. O,
control; O, 50 µg/ml cordycepin ; 0, 2.5 µg/ml cordycepin; A, 20 µg/ml cordycepin .
Uridine-14C (43-50 sc/µmole), uridine-3H (20 c/
mmole), reconstituted protein hydrolysate- 14C and
thymidine- 14C (49 µc/µmole) were purchased from
Schwarz Bioresearch, Orangeburg, N.Y., and methyl-
methionine-3H (2c/mmole) from Nuclear Chicago,
DesPlaines, 111. Cordycepin was a gift of the Cancer
Chemotherapy National Service Center of the Na-
tional Institutes of Health and was also purchased
from Sigma Chemical Co., St. Louis. Actinomycin D
was a gift of Merck, Sharpe, and Dohme, West
Point, Pa.
RESULTS
Cordycepin (3' dA) is an analogue of adenosine in
which 3'OH is replaced by 3'H (8). It has been
shown to possess some anti-tumor activity (17).
Experiments on cells in culture have suggested
that the drug may act principally as an inhibitor of
RNA synthesis (8) .
In vitro experiments with the DNA-dependent
RNA polymerase from Micrococcus lysodeikticus have
shown that 3'-deoxy-ATP is incorporated only in
the terminal position of nascent RNA molecules
(9) . Because the analogue has an OH group in the
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FIGURE 2 Sedimentation analysis of RNA from cordycepin-treated cells . 20 ml of cells at a concentration
of 2 X 106/ml were incubated for 10 min with 10 Ag/ml cordycepin and then labeled with uridinc- 14C at a
concentration of 0.1 µc/ml for 10 min (nucleolus, nucleoplasm) or 30 min (cytoplasm) . The extracted
RNA was analyzed on 15-30% SDS-sucrose gradients as described in Materials and Methods, and the
results compared with RNA from untreated cells. Nucleolar RNA was centrifuged at 24,300 rpm for
12.5 hr, and nucleoplasmic RNA at 19,000 rpm for 15 hr in the SW 25 .3 rotor. Cytoplasmic RNA was
centrifuged in the SW 40 rotor at 40,000 rpm for 3 .75 hr.
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2' position, it is apparently accepted by the poly-
merase as a ribonucleotide . A phosphodiester bond
is formed joining the 5' position in 3'dA to the
previously incorporated nucleotide . However, no
further bonds can be formed to the 3' position and
the RNA molecule is terminated.
In this report, the effects of 3'dA on HeLa cell
RNA metabolism are studied . In vivo, premature
termination of RNA occurs in the nucleolus, and
shortened ribosomal precursor molecules are
formed. The other cellular RNA species, except
for tRNA, are relatively insensitive to the drug,
and premature termination has been detected only
in the ribosomal precursor species .
Selectivity
The high molecular weight RNA synthesized
in the nucleolus is the 45S ribosomal precursor
(13, 3) . This molecule has a lifetime of 16-20 min
(19). It is then cleaved to form several short-lived
intermediates (16) and finally 32S RNA, which
remains in the nucleolus for further processing, and
18S RNA which is exported rapidly to the cyto-
plasm. When radioactive uridine is incorporated
for a time less than the lifetime of 45S RNA (e .g
10 min), the radioactivity in the nucleolus is found
associated principally with completed 45S RNA
and a small population of incompletely synthesized
molecules (20) .
FIGURE 3 The suppression of labeled cytoplasmic ribosomal RNA in cordycepin-treated cells. 10 ml of
cells at 2 X 106/ml per sample were treated with 20 µg/ml cordycepin for 10 min and then labeled for
60 min with uridine-14C as described in Fig. 2. The extracted RNA was analyzed on 15-30% c SDS-sucrose








Fig. 1 shows the effect of various concentrations
of 3'dA on the incorporation of labeled precursors
into whole cell TCA-precipitable material. A con-
centration of 25 µg/ml depresses uridine incor-
poration (total RNA synthesis) by 50%, while
thymidine incorporation (DNA synthesis) and
amino acid incorporation (protein synthesis) are
unaffected at 50 µg/ml. The insensitivity of DNA
and protein synthesis shows that 3'dA does not
directly interfere with general cell metabolism.
The principal site of action of 3'dA is the
nucleolus. Cells were pretreated with 3'dA for 10
min and then labeled with uridine- 14C for 10 or 30
min as indicated. RNA was extracted from the
principal cell fractions and analyzed on sucrose
gradients. The results are shown in Fig. 2. The
effect on nucleolar RNA synthesis is dramatic .
Both the amount and size distribution of nucleolar
RNA synthesized are markedly affected by 3'dA .
In contrast, nucleoplasmic heterodisperse RNA is
unaffected in size or amount . The labeling of cyto-
plasmic cRNA is slightly depressed, but the RNA
synthesized in the presence of 3'dA appears to
have a normal size distribution.
The inhibition of nucleolar synthesis results in
suppression of ribosomal RNA entering the cyto-
plasm in 3'dA-treated cells . This is shown clearly
(Fig. 3) when cells are labeled for 60 min . The
amount of labeled 18S has decreased to 25% of
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513FIGURE 4 Sedimentation analysis of nucleolar RNA synthesized at various concentrations of cordycepin . 20-
in] cell samples at a concentration of 2 X 106/ml were suspended in methionine-free medium containing
adenosine and guanosine at a concentration of 2 X 10-6 M and treated with cordycepin at the indicated
concentrations. [Methyl-3H]-methionine was added at a concentration of 10 µc/ml, and 1 min later
uridine-14C was added for 10 min as in Fig. 2. -p-p-, 14C; -A A-, 3H. 15-30% SDS-su-
crose gradients of nucleolar RNA were centrifuged in the SW 25.3 rotor at 25,000 rpm for 11.3 hr.
control, and the production of 28S has been com-
pletely suppressed . Thi3 relative sensitivity of two
species will be considered in detail later . The
partial suppression of tRNA synthesis is also ap-
parent in the drug-treated cells .
Effect on Nucleolar RNA
The effect of 3'dA on nucleolar rRNA synthesis
was examined more closely. Increasing the con-
centration of 3'dA decreases the size of the species
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labeled in a 10-min pulse as measured by sedimen-
tation (Fig . 4).
The appearance of small ribosomal precursor
molecules is due to either premature chain termi-
nation or decrease in the rate of transcription . A
comparison of a short and long nucleolar labels
shows that the amount of partial ribosomal pre-
cursor molecules increases with the length of label-
ing time for at least 30 min (40 min after addition




peak of completed 45S molecules (Fig . 5) . There-
fore, the short chains seen in a 10-min pulse do not
elongate to become 45S RNA molecules. It appears
that these RNA molecules are prematurely ter-
minated and are not precursors to 45S RNA .
Fig. 6 shows that there is no cumulative effect
of 3'dA on the nucleolar rRNA-synthesizing ma-
chinery. 10-min pulses at various times up to 1 hr
after 3'dA addition give virtually identical results .
FIGURE 5 Long vs. short label of nucleolar RNA in untreated and cordycepin-treated cells . Cordycepin was
at a concentration of 10 µg/ml. Samples of 20 ml of cells at a concentration of 2 X 106 cells/ml were
labeled as in Fig . 2. 15-30% SDS-sucrose gradients of nucleolar RNA were centrifuged in the SW 25.3
rotor at 24,300 rpm for 12.5 hr.
Therefore, the result of the long incorporation in
the presence of 3'dA shown in Fig . 5 is not due to
progressive deterioration in nucleolar synthesis.
The experimental results presented here are
consistent with the presumed role of 3'dA as a
chain terminator. Incomplete rRNA precursor
molecules are made at a constant rate, and their
size is inversely related to 3'dA concentration .
The nucleolar RNA shown in Fig. 4 was also




labeled with methionine. The methylation of
ribosomal precursor RNA has been previously
shown to occur shortly after synthesis (20). The
amount of methyl label relative to uridine label in
the 3'dA produced chains is similar to that in nor-
mal 45S precursor.
Processing of Partial 155 Molecules
The fate of incomplete 45S molecules was in-
vestigated. Cordycepin-treated cells were labeled
for 10 min with uridine- 3H. A high concentration
of actinomycin was added so as to prevent addi-
tional synthesis, and incubation was continued so
as to allow processing. An aliquot of cells was re-
moved before incubation in actinomycin, after 25
min and after 90 min in actinomycin. Another cul-
ture was labeled with uridine-14C and treated
similarly except that cordycepin was omitted . At
each time point, 3H- and '4C-labeled samples were
mixed and harvested. Fig. 7 shows nucleolar RNA
after the 10-min label, nucleolar RNA after 25-min
incubation in actinomycin, and cytoplasmic RNA
after 90-min incubation in actinomycin . The
amount of label in 45S, 32S, and 18S species of
RNA was estimated, and the results are presented
in Table I.
The experiment was designed to determine
whether partially completed ribosomal precursor
FRACTION No .
FIGURE 6 Labeling of nucleolar RNA at various times after addition of cordycepin . 20 ml of cells (2 X 106
cells/ml) per sample were treated with 10 µg/ml of cordycepin and labeled, as in Fig. 2, with uridine-14C
for 10-min periods at different times after addition of cordycepin. 15-30% c SDS-sucrose gradients of
nucleolar RNA were centrifuged in the SW 25.3 rotor for 16 hr at 21,000 rpm.
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molecules could give rise to either 18S or 32S
products. The use of double label permits a com-
parison of cordycepin-treated with untreated cells
which is independent of recovery. The use of high-
resolution acrylamide gel analysis permits an es-
timate of the amount of completed 45S precursor
formed in the drug-treated cells .
The amount of each RNA species in cordycepin-
treated cells was compared to that in untreated
cells, and the results are presented in Table II as
the ratio of 3H cpm (treated) to 14C cpm (un-
treated). This ratio gives the relative amounts of
each species and will be the same for 45S, 32S, and
18S if 32S and 18S in cordycepin-treated cells
arise from whole 45S molecules, as is the case in
untreated cells. Clearly, the relative amounts of
32S RNA are the same as for 45S . Thus, radio-
activity present in 32S RNA can be accounted
for by the 45S molecule present before incubation
in actinomycin. A very different result is obtained
for 18S RNA. Here, there is more than twice as
much 18S RNA in the cordycepin-treated cells
than can be derived from complete 45S molecules
present before incubation in actinomycin . It is
concluded that incomplete precursor molecules
can give rise to 18S, while only whole (or almost
whole) 45S molecules serve as precursor to 32S .









































FIGURE 7 Fate of incomplete ribosomal precursor molecules made in the presence of cordycepin . 30 ml of
cells (2 X 106 cells/ml) were incubated with 20 pg/ml cordycepin for 10 min. Uridine-311 was then added
at a concentration of 5 •c/ml. 10 min later, actinomycin was added at a concentration of 10•g/ml, and
the incubation was continued. Another culture was labeled with 0 .2,uc/ml uridine- 14C and was similarly
treated except that cordycepin was omitted . 10-m1 samples from each of the two cultures were removed
immediately after addition of actinomycin, after 25-min incubation in actinomycin, and after 90-min
incubation in actinomycin. Simultaneous samples from the 3H-labeled culture (cordycepin treated) and
from the 19C-labeled culture (untreated) were mixed before harvesting . Nucleolar RNA was analyzed
by electrophoresis on 2.6% o acrylamide gels as described in Materials and Methods. Electrophoresis was
done at 10 v/cm for 4 hr. Cytoplasmic RNA was analyzed on 15-30% SDS-sucrose gradients centrifuged
at 25,000 rpm for 17.5 hr in the SW 25 .3 rotor.    0---0, 3H; -	Q-
	
Q 14C.
incubation in actinomycin, because 25 min is not
sufficient time for all of the 28S RNA to leave the
nucleus in the presence of actinomycin .
DISCUSSION
Cordycepin (3'-deoxyadenosine) resembles the








transported across the cell membrane and phos-
phorylated by the cellular enzymes (21) . In this
report, it is shown that cordycepin apparently
causes the nucleolar polymerase to produce pre-
maturely terminated RNA chains .
Other workers have suggested additional possi-
ble sites of inhibition by the drug cordycepin .
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3'-dATP has been shown to inhibit ribose phos-
phate phosphokinase which catalyzes the reaction
ribose-5-P + ATP -> PRPP + AMP (22, 30) .
Cordycepin has also been shown to be an inhibitor
of phosphoribosylphosphate amidotransferase
which catalyzes the reaction PRPP + glutamine
5-phosphoribosylamine + glutamate (23).
Both of these enzymes are involved in the initial
steps in purine biosynthesis. Thus, there is the
possibility that, in addition to the effects described
here, cordycepin might cause a partial inhibition
of the synthesis of endogenous purines. This does
not appear to happen in HeLa cells with the
concentrations of drug used in these experiments .
The rate of DNA synthesis, as measured by the
incorporation of radioactive thymidine, is unaf-
fected by cordycepin for at least 85 min. In addi-
tion, except for the nucleolar and tRNA, the
species of RNA examined show very little inhibi-
tion by cordycepin. Both these findings suggest
that no significant reduction in supply of available
purines has occurred under the experimental
conditions used. The insensitivity of amino acid
incorporation to cordycepin suggests that energy
metabolism is unaffected at these concentrations .
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The most striking finding is the effect of cordy-
cepin on nucleolar synthesis . Almost no complete
ribosomal precursor molecules are formed in the
presence of the concentrations of the drug used in
these experiments. In contrast, the synthesis of high
molecular weight heterodisperse RNA is affected
slightly, if at all. The simplest explanation for this
selectivity is the existence of two distinct types of
polymerase, one in the nucleolus, sensitive to the
drug, and another in the nucleoplasm, insensitive
to the drug. There is some evidence that two dis-
tinct RNA polymerases may, in fact, exist in the
nucleolus (24-28) . One such polymerase activity,
activated by magnesium, produces a reaction
product the base composition of which is similar to
that of ribosomal RNA . The magnesium-activated
activity has been shown by radioautography to be
localized in the nucleolus. A distinct polymerase
activity is activated by manganese . The reaction
product resembles DNA in base composition, and
it has been localized in the nucleoplasm by radio-
autography. The explanation of the results of this
investigation would be that the magnesium-acti-
vated, nucleolar-localized enzyme, is sensitive to
cordycepin. The suppression of tRNA synthesis by
cordycepin suggests the possibility of a third dis-
tinct polymerase.
There are at least two possible explanations for
the relative insensitivity of the nonnucleolar RNA
polymerases to the drug . These are : (1) The nu-
cleoplasmic RNA polymerase can distinguish be-
tween a true ribonucleotide and the compound
used here which has a reduced 3' position . (2) The
lack of sensitivity may be only apparent . If the
extranucleolar enzymes can complete a 5' - 2'
phosphodiester linkage, then the cordycepin mole-
cule may be incorporated internally, and this in-
corporation would result in an apparently normal
rate of synthesis. The drug will, of course, have
activity only in a polymerase system in which the
incoming nucleotide is joined by its 5' position to
the preexisting polynucleotide.
The experiment shown in Fig . 7 indicates that
the ribosomal precursor apparently must be nearly
complete before it can give rise to a 32S molecule .
In contrast, 18S molecules clearly are derived from
incomplete precursor molecules . One possible ex-
planation is that the 32S region is located near the
3' end of the 45S molecule and is completed only
when 45S RNA is nearly completed . The 18S
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10' Label 18S 2257 1057
90' Actinomycinprecursor which is closer to the 5' end and is syn-
thesized first. However, completion of the 45S
molecule may be prerequisite for the production of
32S RNA, irrespective of the location of the 32S
region on the precursor molecule .
It is interesting to note that the results presented
here explain an earlier observation of Frederiksen
and Klenow (29). They observed that crodycepin
suppressed the labeling of RNA in one of two nu-
clear fractions and in the cytoplasm. Apparently,
their inhibited nuclear fraction corresponds to the
nucleolar fraction . They also used relatively long
labeling times, and most of the labeled RNA in
the cytoplasm would be ribosomal . The inhibition
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